<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21979875</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>04</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2630</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>31</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International ophthalmology</Title>
                <ISOAbbreviation>Int Ophthalmol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Correlation of macular thickness and posterior hyaloid change following bevacizumab and triamcinolone in diffuse diabetic macular edema in middle-aged patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>363-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10792-011-9464-6</ELocationID>
            <Abstract>
                <AbstractText Label="UNLABELLED">To compare changes in posterior vitreous detachment (PVD) following intravitreal injection of bevacizumab and triamcinolone in diffuse diabetic macular edema in middle-aged type 2 diabetes patients and to correlate this change with change in central macular thickness (CMT).</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">cross sectional study. Fifteen consecutive patients treated by intravitreal bevacizumab (group A) and ten patients treated by intravitreal triamcinolone (group B). Institutional study carried out by retrospective analysis of patient registers including serial optical coherence tomography (OCT) images at baseline, and after 1 and 4 months. A central macular thickness (CMT) and vitreomacular relationship was noted on OCT. PVD was graded on a linear scale (0-4). Change in grade of PVD was correlated with change in CMT at each follow-up. At month 4, the decrease in mean CMT from baseline was 51.2 μ (P = 0.000) and 45 μ (P = 0.022) in group A and group B, respectively, with no significant difference between the two groups (P = 0.874). A change in grades of PVD from baseline to month 4 was significant in both group A (P = 0.001) and group B (P = 0.004) with no significant difference between the two groups (P = 0.906). A significant correlation between change in PVD and reduction of CMT was observed in group A (P = 0.011) but not in group B (P = 0.315). Both bevacizumab and triamcinolone caused a significant reduction in macular thickness and a significant change in grade of PVD. Change in PVD played an influential role in the reduction of macular thickness following bevacizumab.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ghosh</LastName>
                    <ForeName>Sambuddha</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Regional Institute of Ophthalmology, Kolkata, 700073, India. sambuddhaghosh@gmail.com</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dutta</LastName>
                    <ForeName>Jayanta</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukhopadhyay</LastName>
                    <ForeName>Subhalakshmi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhaduri</LastName>
                    <ForeName>Gautam</ForeName>
                    <Initials>G</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int Ophthalmol</MedlineTA>
            <NlmUniqueID>7904294</NlmUniqueID>
            <ISSNLinking>0165-5701</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D020533">Angiogenesis Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2S9ZZM9Q9V</RegistryNumber>
                <NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>F446C597KA</RegistryNumber>
                <NameOfSubstance UI="D014222">Triamcinolone Acetonide</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D020533" MajorTopicYN="N">Angiogenesis Inhibitors</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000068258" MajorTopicYN="N">Bevacizumab</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003930" MajorTopicYN="N">Diabetic Retinopathy</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058449" MajorTopicYN="N">Intravitreal Injections</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008266" MajorTopicYN="N">Macula Lutea</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008269" MajorTopicYN="N">Macular Edema</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014222" MajorTopicYN="N">Triamcinolone Acetonide</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020255" MajorTopicYN="N">Vitreous Detachment</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2011</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2011</Year>
                <Month>09</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>10</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>4</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21979875</ArticleId>
            <ArticleId IdType="doi">10.1007/s10792-011-9464-6</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Ultrasound. 2010 Feb;38(2):66-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19953626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Ophthalmol. 2008 May-Jun;18(3):469-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18465737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Middle East Afr J Ophthalmol. 2010 Jul;17(3):250-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20844681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 1987 Jul;94(7):761-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3658348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 2009 Nov;116(11):2182-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19796823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):15-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20665044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 1984 Dec;91(12):1464-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6521986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 2004 May;27(5):1047-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15111519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Retina. 2008 Nov-Dec;28(10):1435-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18628722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Ophthalmol. 2005 Aug;140(2):184-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16086944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmol Clin North Am. 2004 Mar;17(1):21-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15102511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Ophthalmol. 2005 Jan;139(1):112-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15652835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Ophthalmol. 2011 May;89(3):203-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21044274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Ophthalmol. 1995 Sep;113(9):1144-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7661748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trans Am Ophthalmol Soc. 2005;103:537-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17057817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 2009 Jan;116(1):73-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19118698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 2011 Apr;118(4):636-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21055812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Ophthalmol. 2001 Oct;119(10):1475-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11594947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 1997 Mar;104(3):473-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9082275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Ophthalmol. 2000 Feb;118(2):286-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10676801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 2010 Jun;117(6):1087-1093.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20299105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1009-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19294405</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Retina. 2008 Mar;28(3):410-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18327132</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
